Efficacy of Mepolizumab Treatment on Oral Corticosteroid-Dependent Severe Eosinophilic Asthma Patients with Chronic Rhinosinusitis with Nasal Polyps: Single Center Real Life Study.

CONCLUSION: This is the first real-life study evaluating the short-term efficacy of mepolizumab treatment on the OCS dependant SEA-CRSwNP. This study demonstrates that mepolizumab is an effective and safe biologic for the treatment of this severe asthma subphenotype. PMID: 32093447 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32093447?dopt=Abstract

Source: Turkish Journal of Medical Sciences - February 27, 2020 Category: General Medicine Tags: Turk J Med Sci Source Type: research